Curriculum Vitae: [download]

Education:

  • Pharm.D. University of Rhode Island School of Pharmacy
  • B.S. University of Connecticut School of Pharmacy - summa cum laude
    • TPGA = 3.98, ranked #1 in class
  • B.A. Rutgers State University - Major: Chemistry

Honors/Awards:

  • Martec Recognition Award for Drugs and Dosage Forms
  • Smith Kline & French Laboratories Award for Superior Achievement in Clinical Pharmacy
  • Phi Kappa Phi Honor Society
  • Rho Chi Honor Society
  • Louis F. Villa Award for highest cumulative average
  • University of Connecticut Pharmacy School Dean’s Award
  • Representative of the Candidates of the School of Pharmacy - Commencement Ceremonies
  • National Honor Society
  • Scholarship-Women’s Auxiliary of the Society of Professional Engineers of Union County, NJ

Professional Experience:

[2000 - present]

Drug Information Specialist, Drug Information Center, Hartford Hospital.

Present formulary reviews to the Therapeutics Committee, member of the Drug Utilization Evaluation Committee, author of drug information newsletters, develop hospital protocols for medication use, provide drug information and educational inservices to physicians, pharmacists, nurses, hospitals and communities.

[2005 – present]

Adjunct Assistant Professor of Pharmacy Practice – University of Connecticut School of Pharmacy. Precept University of Connecticut School of Pharmacy students who are participating in a Drug Information clinical rotation at Hartford Hospital.

[1997-2000]

Anticoagulation Services Pharmacist at Hartford Hospital, provided independent monitoring of warfarin therapy for orthopedic hip/knee replacement patients and cardiac patients with atrial fibrillation, cardiomyopathy, or cardiac valve replacements. Provided comprehensive education regarding anticoagulation therapy to patients. Adjusted dosing of warfarin based on INR results, medical history of patient, and coadministration of interacting medications or herbal supplements.

[1994-1997]

Clinical pharmacist Hartford Hospital – Surgical floor Health Care Team representative; surgical rounds; support and information for attending physicians, residents, and nurses; implemented drug utilization review comparing the use of antiemetics; screened physician orders for appropriateness of dose, interactions, appropriate adjustment of dose for renal or hepatic failure, appropriateness of antibiotic regimen for patients’ conditions; reviewed medical administration records for errors, interactions, administration scheduling errors, correctness of restrictions regarding food or minerals given in combination with medications; monitored for over- or underutilization of pain medications; monitored for timely conversion of IV to oral medications.

[1988- 1993]

Retail Pharmacist, CVS Pharmacy. Manager 1991-1993.

 

Publications/Abstracts/Poster Presentations:

  1. Udeh E and Goldman MC. Alvimopan: A peripherally selective opioid mu receptor antagonist. Formulary 2005; 40:176-183.
  2. Goldman MC and Schutzer S. Valdecoxib: A COX-2 inhibitor for treatment of osteoarthritis, rheumatoid arthritis, and primary dysmenorrheal. Formulary 2002; 37: 68-77.
  3. Goldman MC and Quercia RA. Desloratadine: once daily non-sedating antihistamine for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria. Formulary 2001; 36:329-39.
  4. Quercia RA, Keating KP, and Goldman MC. Management of epoetin alpha use in the intensive care unit: a drug use evaluation. Formulary 2006; 41:442-9.
  5. Perkerson K, Quercia RA, Goldman MC, Goddu G, Coleman C. Can a multidisciplinary initiative to increase adverse drug reaction reporting work? Connecticut Medicine 2004; 68(5): 275-78.
  6. Goldman MC, Gannon R, and Quercia RA. Cost effective management of post-operative nausea and vomiting: a risk assessment and multimodal approach. 41st ASHP Midyear Clinical Meeting and Exhibition. Abstract.

Hospital Medication Use Protocols

  1. Acetylcysteine abbreviated protocol for prevention of liver injury following acute liver overdose.
  2. Protocol for use of acetylcysteine for renal protection with contrast agents.
  3. Alcohol withdrawal protocol.
  4. Alprostadil (prostaglandin E1) protocol for the post-liver transplant patient.
  5. Antiemetic protocol in the post-anesthesia care unit.
  6. Diltiazem extended-release automatic substitution protocol.
  7. Donor organ flush and intra-peritoneal irrigation administration protocol in pancreatic transplantation.
  8. Calcium, magnesium, potassium and phosphorous electrolyte replacement protocols.
  9. Epoprostenol (Flolan) treatment protocol.
  10. Haloperidol (Haldol) IV administration protocol for treatment of acute agitation due to delirium.
  11. Immunoglobulins therapeutic equivalence dosing protocol.
  12. Iron sucrose infusion protocol.
  13. Methylprednisolone (Solu-Medrol) collaborative practice protocol for spinal injury.
  14. Moxifloxacin IV to oral formulation automatic conversion protocol.
  15. Nesiritide (Natrecor) use DUE protocol.
  16. Nicardipine (Cardene) protocol.
  17. Oral proton pump inhibitors inpatient automatic conversion protocol.
  18. Pantoprazole (Protonix) prescribing protocol for gastrointestinal reflux disease, erosive esophagitis, Zollinger-Ellison Syndrome and upper gastrointestinal ulcer prophylaxis and maintenance.
  19. Pantoprazole (Protonix) prescribing protocol for prevention of rebleeding.
  20. Phenytoin (Dilantin) IV infusion protocol.
  21. Post-operative nausea and vomiting protocol for inpatients.
  22. Propofol protocol for ICU sedation.
  23. Rasburicase (Elitek) protocol.
  24. Protocol for use of reversal agents for narcotics and benzodiazepines.
  25. Sodium bicarbonate hydration protocol for prevention of contrast-induced nephropathy.
  26. Triiodothyronine IV protocol for administration to heart transplant patients
  27. Triiodothyronine IV protocol for potential organ donors.
  28. Vancomycin collaborative drug management dosing and monitoring protocol.
  29. Intrathecal vancomycin preparation and administration protocol.
  30. Zosyn (piperacillin/tazobactam) continuous infusion collaborative practice protocol.